Triclinic polymorph of bis-[2-methyl-3-(pyridin-2-yl)imidazo[1,5-a]pyridin-2-ium] tetra-chloridocadmium(II).

The crystal structure of the title organic-inorganic hybrid salt, (C(13)H(12)N(3))(2)[CdCl(4)], (I), has been reported with four mol-ecules in the asymmetric unit in a monoclinic cell [Vassilyeva et al. (2021 ▸). RSC Advances, 11, 7713-7722]. While using two different aldehydes in the oxidative cyclization-condensation involving CH(3)NH(2)·HCl to prepare a new monovalent cation with the imidazo[1,5-a]pyridinium skeleton, a new polymorph was obtained for (I) in space group P1 and a unit cell with approximately half the volume of the monoclinic form. The structural configurations of the two crystallographically non-equivalent organic cations as well as the geometry of the moderately distorted tetra-hedral CdCl(4) (2-) dianion show minor changes. In the crystal, identically stacked cations and tetra-chloro-cadmate anions form separate columns parallel to the a axis. The loose packing of the anions leads to a minimal separation of approximately 9.53†à between the metal atoms in the triclinic form versus 7.51†à in the monoclinic one, indicating that the latter is packed slightly more densely. The two forms also differ by aromatic stacking motifs. Similar to the monoclinic polymorph, the triclinic one excited at 364†nm shows an intense unsymmetrical photoluminescent band with maximum at 403†nm and a full width at half maximum of 51†nm in the solid state.